Ms. Lior Hefetz-Giterman

She is an accomplished professional specializing in managing academic projects spanning psychology, psycho-pharmacology, neuropsychology, and psychobiology. With a background in preclinical in vivo research and laboratory work, including behavioral and molecular tools, Lior has contributed significantly to various therapeutic areas. Her expertise ranges from investigating the effects of drugs on behavior to exploring neurodevelopmental models of schizophrenia.

My professional experience includes managing academic projects in the fields of Psychology, Psycho- Pharmacology, Neuropsychology and Psychobiology, as well as preclinical in vivo projects in a wide range of therapeutic areas, integrated in IN VIVO & IN VITRO laboratory work including, behavioral and molecular tools using RNA and DNA extraction, PCR, Real time- PCR (working with rodent models).

 2013-2014- Psycho-Pharmacology B.A Seminar, instructor:  Dr.Sharon Anavi- Goffer, Examined the effects of drugs on behavior and medical uses of cannabis. Psychology Department, Ariel University.

2014-2015- Neuropsychology B.A Seminar, instructor: Dr.Ariela Gigi. Cognitive and visual style tendency among, hearing impaired people from birth, Psychology Department, Ariel University.

2016-2018- M.A Thesis, instructor: Dr.Inna Gaisler-Salomon, investigating Gls1 +/- mice, in aneurodevelopmental model of schizophrenia using behavioral and molecular tools. Psychobiology department, University of Haifa.

2016-2018- Head of Teaching Assistant for Physiological Bases Of Behavior, Department Of Psychobiology, University Of Haifa.

Professional training

2017- 2018- "Clinical window for basic science researchers", Israel Society for Biological Psychiatry, the course aims to uncover to basic science researchers the psychiatric morbidity, treatment, diagnosis and clinical research. The meetings are held by clinical researchers, with direct contact with patients, and discussion about the process of diagnosis.

2021-2022-  "Science In Action" (SIA) company, preclinical in vivo services and promoting potential new therapies towards clinical stages in a wide range of therapeutic areas such as, immunology, surgical models, dermatology, neurodegenerative disorders, kidney dysfunction, metabolic and liver diseases, oncology, and muscular dystrophy, Weizmann Science Park.

2024- Characterization unit, Bar ilan Nanotechnology and advanced materials